Key facts
- It has raised $14.5M; the latest was Later Stage VC ($14.5M) in Mar 2026.
- Notable investors include Jinding Capital, Dalton Venture.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Bangyun Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Bangyun Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bangyun Medical
Manufacturer of surgical wound closure consumables and medical instruments designed for multi-specialty clinical applications. The company focuses on the development, production, and commercialization of high-end surgical sutures and related devices, emphasizing localization of medical consumables and delivering clinically validated products supported by in-house R&D and patented technologies.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2019
- Ownership
- Privately Held (backing)
Bangyun Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bangyun Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bangyun Medical in its N-PORT filings yet. We sweep new filings monthly.